Compile Data Set for Download or QSAR
Found 137 with Last Name = 'de vry' and Initial = 'j'
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176564(US9120756, 26)copy SMILEScopy InChI
Affinity DataKi:  0.100nM ΔG°:  -59.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176564(US9120756, 26)copy SMILEScopy InChI
Affinity DataKi:  0.100nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127310(US8791268, 21)copy SMILEScopy InChI
Affinity DataKi:  0.100nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176555(US9120756, 17)copy SMILEScopy InChI
Affinity DataKi:  0.100nM ΔG°:  -59.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176555(US9120756, 17)copy SMILEScopy InChI
Affinity DataKi:  0.100nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM50000727((R)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-di...)copy SMILEScopy InChI
Affinity DataKi:  0.140nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ06VPPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176554(US9120756, 16)copy SMILEScopy InChI
Affinity DataKi:  0.200nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127312(US8791268, 23)copy SMILEScopy InChI
Affinity DataKi:  0.300nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176559(US9120756, 21)copy SMILEScopy InChI
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176561(US9120756, 23)copy SMILEScopy InChI
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176562(US9120756, 24)copy SMILEScopy InChI
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176554(US9120756, 16)copy SMILEScopy InChI
Affinity DataKi:  0.300nM ΔG°:  -56.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176549(US9120756, 7)copy SMILEScopy InChI
Affinity DataKi:  0.350nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176562(US9120756, 24)copy SMILEScopy InChI
Affinity DataKi:  0.400nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176561(US9120756, 23)copy SMILEScopy InChI
Affinity DataKi:  0.400nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176566(US9120756, 28)copy SMILEScopy InChI
Affinity DataKi:  0.400nM ΔG°:  -55.8kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM21281((11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphth...)copy SMILEScopy InChI
Affinity DataKi:  0.410nMMore data for this Ligand-Target Pair
TargetCannabinoid receptor 1(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM50000727((R)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-di...)copy SMILEScopy InChI
Affinity DataKi:  0.410nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ06VPPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176556(US9120756, 18)copy SMILEScopy InChI
Affinity DataKi:  0.5nM ΔG°:  -55.2kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM21244(2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  0.510nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N0154RPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM21244(2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  0.520nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ06VPPubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM21244(2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  0.540nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N0154RPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127311(US8791268, 22)copy SMILEScopy InChI
Affinity DataKi:  0.700nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176571(US9120756, 40)copy SMILEScopy InChI
Affinity DataKi:  0.800nM ΔG°:  -54.0kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127309(US8791268, 20)copy SMILEScopy InChI
Affinity DataKi:  0.900nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM21244(2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  1.10nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ06VPPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127308(US8791268, 19)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetCannabinoid receptor 1(Rattus norvegicus (rat))
Bayer HealthCare

Curated by PDSP Ki Database
LigandPNGBDBM21244(2-[(1S,2S,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohe...)copy SMILEScopy InChI
Affinity DataKi:  1.15nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N0154RPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176567(US9120756, 29)copy SMILEScopy InChI
Affinity DataKi:  1.20nM ΔG°:  -53.0kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176559(US9120756, 21)copy SMILEScopy InChI
Affinity DataKi:  1.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176565(US9120756, 27)copy SMILEScopy InChI
Affinity DataKi:  1.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176553(US9120756, 15)copy SMILEScopy InChI
Affinity DataKi:  2.10nM ΔG°:  -51.5kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176565(US9120756, 27)copy SMILEScopy InChI
Affinity DataKi:  2.20nM ΔG°:  -51.4kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176583(US9120756, 134)copy SMILEScopy InChI
Affinity DataKi:  2.5nM ΔG°:  -51.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176553(US9120756, 15)copy SMILEScopy InChI
Affinity DataKi:  2.5nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127315(US8791268, 26)copy SMILEScopy InChI
Affinity DataKi:  3.40nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176552(US9120756, 14)copy SMILEScopy InChI
Affinity DataKi:  3.70nM ΔG°:  -50.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176569(US9120756, 33)copy SMILEScopy InChI
Affinity DataKi:  4nM ΔG°:  -49.9kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127303(US8791268, 3)copy SMILEScopy InChI
Affinity DataKi:  4.40nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127317(US8791268, 34)copy SMILEScopy InChI
Affinity DataKi:  4.80nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176563(US9120756, 25)copy SMILEScopy InChI
Affinity DataKi:  5.10nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176550(US9120756, 12)copy SMILEScopy InChI
Affinity DataKi:  5.90nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Bayer AG

Curated by PDSP Ki Database
LigandPNGBDBM86035(BAY 38-7271 | KN 38-7271)copy SMILEScopy InChI
Affinity DataKi:  5.96nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ06VPPubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176568(US9120756, 30)copy SMILEScopy InChI
Affinity DataKi:  6.30nM ΔG°:  -48.7kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176570(US9120756, 39)copy SMILEScopy InChI
Affinity DataKi:  7.20nM ΔG°:  -48.3kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176552(US9120756, 14)copy SMILEScopy InChI
Affinity DataKi:  7.20nMAssay Description:The agonistic or antagonistic effect of the substances to be tested on the rat-species vanilloid receptor 1 (VR1/TRPV1) can be determined using the f...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127316(US8791268, 27)copy SMILEScopy InChI
Affinity DataKi:  7.70nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127316(US8791268, 27)copy SMILEScopy InChI
Affinity DataKi:  7.90nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM176550(US9120756, 12)copy SMILEScopy InChI
Affinity DataKi:  8nM ΔG°:  -48.1kJ/moleT: 2°CAssay Description:The agonistic or antagonistic effect of the substances to be tested on the vanilloid receptor 1 (VR1) can also be determined using the following assa...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q26D5RRGUS Patent
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Gruenenthal GmbH

US Patent
LigandPNGBDBM127315(US8791268, 26)copy SMILEScopy InChI
Affinity DataKi:  9.60nMAssay Description:The FLIPR protocol consists of two substance additions. Initially, the compounds to be tested (10 uM) are pipeted onto the cells and the Ca2+ influx ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BV7F9DUS Patent
Displayed 1 to 50 (of 137 total ) | Next | Last >>
Jump to: